Previous close | 18.10 |
Open | 6.38 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 6.38 - 18.10 |
52-week range | 6.38 - 18.10 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Despite a revenue dip, RSLS demonstrates robust cost management and strategic initiatives poised for future growth.
ReShape Lifesciences ( NASDAQ:RSLS ) Full Year 2023 Results Key Financial Results Revenue: US$8.68m (down 23% from FY...